Exploring Emilin1 and TNF as Novel Strategies for Abdominal Aortic Aneurysm Progression Control

Pharmacology, Toxicology and Pharmaceutical Science

• Tumor Necrosis Factor 100%
• Synapsin I 100%
• Abdominal Aortic Aneurysm 100%
• Elastin 100%
• Cancer Growth Factor 41%
• Inflammation 16%
• Tumor Necrosis Factor Receptor 16%
• Biological Marker 12%
• Aneurysm 12%
• Adverse Event 9%
• Cytokine 6%
• Tumor Necrosis Factor Inhibitor 6%
• Aortic Aneurysm 6%
• Cre Recombinase 6%
• Mouse Strain 6%
• Population Study 3%
• Calcium Antagonist 3%
• Bleeding 3%
• Transforming Growth Factor Beta1 3%
• Infection 3%
• Elimination 3%
• Dipeptidyl Carboxypeptidase 3%
• Angiotensin II 3%
• Rat Model 3%
• Fibrosis 3%
• Essential Hypertension 3%
• Hyperlipidemia 3%
• Genetic Predisposition 3%
• Gelatinase B 3%
• Neuropathy 3%
• Gelatinase A 3%
• Apolipoprotein E 3%
• Bone Fragility 3%
• Arthropathy 3%
• Transcriptome 3%
• Pancreatic Elastase 3%
• Trimethylglycine 3%
• Tumor Necrosis Factor Alpha Converting Enzyme 3%
• Tumor Necrosis Factor Receptor 1 3%
• Tumor Necrosis Factor Receptor 2 3%
• Cardiovascular Disease 3%
• Elastase 3%
• Hypertension 3%

Biochemistry, Genetics and Molecular Biology

• Synapsin I 100%
• Tumor Necrosis Factor 100%
• Elastin 100%
• Cancer Growth Factor 41%
• Tumor Necrosis Factor Receptor 22%
• Blood Plasma 12%
• Blood Pressure 9%
• Macrophage 9%
• Animal Model 6%
• Artery Resistance 6%
• Mouse Strain 6%
• TNF Inhibitor 6%
• Cre Recombinase 6%
• Tissue Perfusion 6%
• Growth Factor Signaling 6%
• Genetics 3%
• Population Research 3%
• Apolipoprotein E 3%
• Enzyme 3%
• Genetic Predisposition 3%
• T Cell 3%
• Transgenics 3%
• Mediator 3%
• Cytokine 3%
• Blood Flow 3%
• TGF Beta 1 3%
• Cell Death 3%
• Protease 3%
• Oxidative Stress 3%
• Immune Response 3%
• Elastase 3%
• MMP9 3%
• Gelatinase B 3%
• Gelatinase A 3%
• MMP2 3%
• Trimethylglycine 3%
• Rat Model 3%
• ADAM17 3%
• Proinflammatory Cytokine 3%
• Immunoregulation 3%
• Angiotensin 3%
• Transcriptome 3%
• Programmed Cell Death 3%
• Proteolysis 3%
• Drug Therapy 3%
• Pancreatic Elastase 3%

Immunology and Microbiology

• Tumor Necrosis Factor 100%
• Cancer Growth Factor 65%
• Tumor Necrosis Factor Receptor 25%
• Blood Plasma 20%
• Macrophage 15%
• Blood Pressure 15%
• Extracellular Matrix 15%
• Inflammation 15%
• Inflammation Response 10%
• Vascular Smooth Muscle Cell 10%
• TNF Inhibitor 10%
• Mouse Strain 10%
• Artery Resistance 10%
• Aortic Wall 10%
• Proinflammatory Cytokine 5%
• Cytokine 5%
• T Cell 5%
• Protein Degradation 5%
• Connective Tissue 5%
• Blood Flow 5%
• Transforming Growth Factor Beta1 5%
• Infectious Disease 5%
• Population Research 5%
• Immune Response 5%
• Transgenics 5%
• Oxidative Stress 5%
• Smooth Muscle Cell 5%
• Genetic Predisposition 5%
• Rat Model 5%
• Mediator 5%
• Cell Death 5%
• Arthropathy 5%
• Immunoregulation 5%
• Tumor Necrosis Factor Receptor 1 5%
• Transcriptome 5%
• Lower Limb 5%
• ADAM17 5%
• Blood Vessel Wall 5%
• Abdominal Aorta 5%
• Tumor Necrosis Factor Receptor 2 5%
• Cardiovascular System 5%
• Programmed Cell Death 5%
• Drug Therapy 5%
• Apolipoprotein E 5%
• Angiotensin 5%
• Infection 5%